Skip to main content

Advertisement

Log in

Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT)

  • Original Article
  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

Osteonecrosis of the jaw (ONJ) in patients on long-term bisphosphonate Therapy (BPT) has been reported with increasing frequency in literature over the past 4 years. Therapy for this condition is still a dilemma. Temporary suspension of BPT offers no short-term benefits; hyperbaric oxygen has no proven efficacy and therefore is not recommended. Intermittent or continuous antibiotic therapy with surgical debridement can be beneficial to palliate the symptoms. Er:YAG laser can be used to eliminate necrotic bone portions by partial or total resection as an alternative to conventional rotary devices. In our study, 91 patients affected by ONJ-BP lesion, for a total of 115 ONJ sites were observed between January 2004 and May 2008 (Department of Odontostomatology, University of Parma). Fifty-five ONJ sites were considered for this study in four different groups, retrospectively identified on the basis of treatment performed (G1–G4). G1: 13 ONJ-BP sites were treated with medical therapy (amoxicillin 1gr x 3/die per os with metronidazole 250 mg x 2/die per os) for at least 2 weeks; G2: 17 ONJ-BP sites received medical treatment in association with cycles of low-level laser therapy (LLLT) applications performed using an Nd:YAG laser (1,064 nm) once a week for 2 months; G3: 13 ONJ-BP sites were surgically treated (sequestrectomy of necrotic bone, debridement, corticotomy/surgical removal of alveolar and/or cortical bone); G4: 12 ONJ-BP sites were treated with surgical therapy performed using an Er:YAG laser (2,940 nm) in association with LLLT. Clinical success has been defined for each treatment performed as: (a) complete mucosal healing free from signs and symptoms (classified as stage “0”) or (b) transition from a higher to a lower stage (Ruggiero staging) for at least 3 months. All the ONJ-BP sites treated with Er:YAG laser (G4 group) had a clinical improvement (100%) and 87.5% of sites had a complete mucosal healing with a mean follow-up of 13 months. The result obtained in the G4 is extremely significant in comparison with those obtained by medical treatment alone or in a traditional surgical approach. Thanks to the high degree of affinity of this wavelength for water and hydroxyapatite, both soft and bone tissues can be easily treated. This technique can also be used for conservative operations whereby necrotic bone is vaporized until healthy bone is reached. In addition, an additional advantage of the Er:YAG laser is its bactericidal and possible biostimulatory action, accelerating the healing of both soft tissues and bone tissues, in comparison to conventional treatments. In conclusion, from our experience, it is possible to observe that an early conservative surgical approach with Er:YAG laser associated with LLLT, for BP-induced ONJ could be considered as more efficient in comparison with medical therapy or other conventional techniques.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

Similar content being viewed by others

References

  1. Corrado A, Cantatore FP (2005) The bisphosponates: chemical characteristics, skeletal biological effects and extra-skeletal effects. Reumatismo 57:142–153

    CAS  PubMed  Google Scholar 

  2. Vescovi P (2008) Osteonecrosi dei mascellari e bisfosfonati: terapia odontoiatrica e prevenzione. Ed Tecniche nuove - Mi.

  3. Ferretti G, Fabi A, Carlini P, Papaldo P, Cordiali Fei P, Di Cosimo S et al (2005) Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients. Oncology 69:35–43. doi:10.1159/000087286

    Article  CAS  PubMed  Google Scholar 

  4. Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567–1575. doi:10.1016/j.joms.2005.07.010

    Article  PubMed  Google Scholar 

  5. Ruggiero S, Gralow J, Marx RE, Hoff AO, Schubert MM, Huryn JM, Toth B, S M, Damato K, Valero V (2006) Practical guidelines for the prevention, diagnosis and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract 2:7–13. doi:10.1200/JOP.2.1.7

    Article  Google Scholar 

  6. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D et al (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479–1491. doi:10.1359/jbmr.0707onj

    Article  PubMed  Google Scholar 

  7. Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65:415–423. doi:10.1016/j.joms.2006.10.061

    Article  PubMed  Google Scholar 

  8. Ruggiero SL, Drew SJ (2007) Osteonecrosis of the jaws and bisphosphonate therapy. J Dent Res 86:1013–1021. doi:10.1177/154405910708601101

    Article  CAS  PubMed  Google Scholar 

  9. Advisory Task Force on Bisphosphonate Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65:369–376. doi:10.1016/j.joms.2006.11.003

    Google Scholar 

  10. Bertoldo F, Dalle Carbonare L, Pancheri S, Lo Cascio V, Nocini PF (2007) Osteonecrosi della mandibola associate alla terapia con bifosfonati. Aggiornamento in tema di bifosfonati - Organo ufficiale del GIBIS (Gruppo Italiano per lo studio dei Bisfosfonati).VIII:1–31

  11. Merigo E, Manfredi M, Meleti M, Corradi D, Vescovi P (2005) Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. J Oral Pathol Med 34:613–617. doi:10.1111/j.1600-0714.2005.00351.x

    Article  CAS  PubMed  Google Scholar 

  12. Merigo E, Manfredi M, Meleti M, Guidotti R, Ripasarti A, Zanzucchi E et al (2006) Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases. Acta Biomed. 77:109–117

    CAS  PubMed  Google Scholar 

  13. Freiberger JJ, Padilla-Burgos R, Chhoeu AH, Kraft KH, Boneta O, Moon RE et al (2007) Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series. J Oral Maxillofac Surg 65:1321–1327. doi:10.1016/j.joms.2007.03.019

    Article  PubMed  Google Scholar 

  14. Adornato MC, Morcos I, Rozanski J (1939) (2007) The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. J Am Dent Assoc 138:971–977

    Google Scholar 

  15. Longobardi G, Boniello R, Gasparini G, Pagano I, Pelo S (2007) Surgical therapy for osteonecotic lesions of the jaws in patients in therapy with bisphosphonates. J Craniofac Surg 18:1012–1017. doi:10.1097/scs.0b013e3180f611ef

    Article  PubMed  Google Scholar 

  16. Vescovi P, Manfredi M, Merigo E, Meleti M (2008) Early surgical approach preferable to medical therapy for bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 66:831–832. doi:10.1016/j.joms.2007.11.025

    Article  PubMed  Google Scholar 

  17. Bertrand MF, Hessleyer D, Muller-Bolla M, Nammour S, Rocca JP (2004) Scanning electron microscopic evaluation of resin-dentin interface after Er:YAG laser preparation. Lasers Surg Med 35:51–57. doi:10.1002/lsm.20063

    Article  PubMed  Google Scholar 

  18. Curti M, Rocca JP, Bertrand MF, Nammour S (2004) Morphostructural aspect of Er:YAG prepared class V cavities. J Clin Lasers Surg Med 22:216–220

    Google Scholar 

  19. Karu T (1989) Laser biostimulation: a photobiological phenomenon. J Photochem Photobiol 3:638–640

    Article  CAS  Google Scholar 

  20. Guzzardella GA, Fini M, Torricelli P, Giavaresi G, Giardino R (2002) Laser stimulation on bone defect healing: an in vitro study. Lasers Med Sci 17:216–220. doi:10.1007/s101030200031

    Article  CAS  PubMed  Google Scholar 

  21. Ueda Y, Shimizu N (2003) Effects of pulse frequency of low-level laser therapy (LLLT) on bone nodule formation in rat calvarial cells. J Clin Laser Med Surg 21:271–277. doi:10.1089/104454703322564479

    Article  PubMed  Google Scholar 

  22. Dortbudak O, Haas R, Mailath-Pokorny G (2002) Effect of low-power laser irradiation on bony implant sites. Clin Oral Implants Res 13:288–292. doi:10.1034/j.1600-0501.2002.130308.x

    Article  PubMed  Google Scholar 

  23. Chen CH, Tsai JL, Wang YH, Lee CH, Chen JK, Huang MH (2008) Low-level laser irradiation promotes cell proliferation and mRNA expression of type I collagen and decorin in porcine Achilles tendon fibroblasts in vitro. J Orthop Res; Epub ahead

  24. Stein E, Koehn J, Sutter W, Wendtlandt G, Wanschitz F, Thurnher D et al (2008) Initial effects of low-level laser therapy on growth and differentiation of human osteoblast-like cells. Wien Klin Wochenschr 120:112–117. doi:10.1007/s00508-008-0932-6

    Article  CAS  PubMed  Google Scholar 

  25. Merigo E, Vescovi P, Manfredi M, Fornaini C, Bertrand MF, Rocca JP (2007) Low-level laser therapy and bone healing. First Meeting of European Division of WFLD (World Federation for Laser in Dentistry). Nice:44

  26. Vescovi P, Manfredi M, Merigo E, Fornaini C, Meleti M, D'Aleo P, Bonanini M (2006) Jaws bone necrosis in patients taking bisphosphonates (Gestione dell'osteonecrosi dei mascellari da bifosfonati:uso della biostimolazione laser). Dent Cadmos 74:71–78

    Google Scholar 

  27. Vescovi P, Merigo E, Manfredi M, Meleti M, Fornaini C, Bonanini M et al (2008) Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases. Photomed Laser Surg 26:37–46. doi:10.1089/pho.2007.2181

    Article  PubMed  Google Scholar 

  28. Vescovi P, Merigo E, Meleti M, Manfredi M (2006) Bisphosphonate-associated osteonecrosis (BON) of the jaws: a possible treatment? J Oral Maxillofac Surg 64:1460–1462. doi:10.1016/j.joms.2006.05.042

    Article  PubMed  Google Scholar 

  29. Ando Y, Aoki A, Watanabe H, Ishikawa I (1996) Bactericidal effect of erbium YAG laser on periodontopathic bacteria. Lasers Surg Med 19:190–200. doi:10.1002/(SICI)1096-9101(1996)19:2<190::AID-LSM11>3.0.CO;2-B

    Article  CAS  PubMed  Google Scholar 

  30. Folwaczny M, Mehl A, Aggstaller H, Hickel R (2002) Antimicrobial effects of 2.94 micron Er:YAG laser radiation on root surfaces: an in vitro study. J Clin Periodontol 29:73–78. doi:10.1034/j.1600-051x.2002.290111.x

    Article  PubMed  Google Scholar 

  31. Pourzarandian A, Watanabe H, Aoki A, Ichinose S, Sasaki KM, Nitta H et al (2004) Histological and TEM examination of early stages of bone healing after Er:YAG laser irradiation. Photomed Laser Surg 22:342–350. doi:10.1089/pho.2004.22.342

    Article  PubMed  Google Scholar 

  32. Pourzarandian A, Watanabe H, Ruwanpura SM, Aoki A, Noguchi K, Ishikawa I (2005) Er:YAG laser irradiation increases prostaglandin E production via the induction of cyclooxygenase-2 mRNA in human gingival fibroblasts. J Periodontal Res 40:182–186. doi:10.1111/j.1600-0765.2005.00789.x

    Article  CAS  PubMed  Google Scholar 

  33. Takasaki AA, Aoki A, Mizutani K, Kikuchi S, Oda S, Ishikawa I (2007) Er:YAG laser therapy for peri-implant infection: a histological study. Lasers Med Sci 22:143–157. doi:10.1007/s10103-006-0430-x

    Article  PubMed  Google Scholar 

  34. de Mello ED, Pagnoncelli RM, Munin E, Filho MS, de Mello GP, Arisawa EA et al (2008) Comparative histological analysis of bone healing of standardized bone defects performed with the Er:YAG laser and steel burs. Lasers Med Sci 23:253–260. doi:10.1007/s10103-007-0475-5

    Article  PubMed  Google Scholar 

  35. Vescovi P, Merigo E, Manfredi M, Fornaini C, Rocca JP Nammour S (2007) Er:YAG and Nd:YAG laser applications in bisphosphonate-related jaws osteonecrosis:our experience in 60 patients. Lasers in medical science. Abstracts of the 17th ISLSM (International Society Laser Surgery and Medicine) and 22nd IALMS (International Academy Laser Medicine and Surgery):43

  36. Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6:65–70

    Google Scholar 

  37. Hochberg Y (1988) A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75:800–803. doi:10.1093/biomet/75.4.800

    Article  Google Scholar 

  38. Hommel G (1988) A stagewise rejective multiple test procedure based on a modified Bonferroni test. Biometrika 75:383–386. doi:10.1093/biomet/75.2.383

    Article  Google Scholar 

  39. Shaffer JP (1995) Multiple hypothesis testing. Annu Rev Psychol 46:561–584.

    Google Scholar 

  40. Sarkar S (1998) Some probability inequalities for ordered MTP2 random variables: a proof of Simes conjecture. Ann Stat 26:494–504. doi:10.1214/aos/1028144846

    Article  Google Scholar 

  41. Sarkar S, Chang CK (1997) Simes' method for multiple hypothesis testing with positively dependent test statistics. J Am Stat Assoc 92:1601–1608. doi:10.2307/2965431

    Article  Google Scholar 

  42. Wright SP (1992) Adjusted P-values for simultaneous inference. Biometrics 48:1005–1013. doi:10.2307/2532694

    Article  Google Scholar 

  43. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B Methodolog 57:289–300

    Google Scholar 

  44. Benjamini Y, Yekutieli D (2001) The control of the false discovery rate in multiple testing under dependency. Ann Stat 29

  45. (2008) R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria http://wwwR-projectorg

  46. Tuner J, Hode L (2002) Laser therapy. Clinical practice and scientific background. Prima Books Ed Grangesberg Sweden:152–154

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paolo Vescovi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vescovi, P., Manfredi, M., Merigo, E. et al. Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT). Lasers Med Sci 25, 101–113 (2010). https://doi.org/10.1007/s10103-009-0687-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10103-009-0687-y

Keywords

Navigation